Retatrutide is an investigational medicine currently under clinical development for the treatment of obesity and type 2 diabetes
Human data is limited but promising: Preclinical Studies : Over 100 publications, including those on PubMed, show BPC-157's efficacy in models of wound healing, GI protection, and CNS recovery
Yes, most lab work is completed directly at our South Reno clinic, allowing for faster results and a more streamlined experience
Additionally, most insurance policies were written before GLP-1 medications became mainstream for weight management, and formularies have not been updated to reflect current clinical guidelines
If you have not had recent labs or your Flow Wellness provider recommends additional screening, we offer a significant cash pay discount for labs or you can bill your insurance for lab work
BPC-157 Molecular Specifications The following technical data defines the chemical profile of BPC-157 (Body Protection Compound 157) available through our wholesale catalog